Patient-tailored antithrombotic therapy following percutaneous coronary intervention

Dual antiplatelet therapy has long been the standard of care in preventing coronary and cerebrovascular thrombotic events in patients with chronic coronary syndrome and acute coronary syndrome undergoing percutaneous coronary intervention, but choosing the optimal treatment duration and composition...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sangen, Niels M R, Rozemeijer, Rik, Chan Pin Yin, Dean R P P, Valgimigli, Marco, Windecker, Stephan, James, Stefan K, Buccheri, Sergio, ten Berg, Jurriën M, Henriques, José P S, Voskuil, Michiel, Kikkert, Wouter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
State of the Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244639/
https://www.ncbi.nlm.nih.gov/pubmed/33515031
http://dx.doi.org/10.1093/eurheartj/ehaa1097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244639/
https://www.ncbi.nlm.nih.gov/pubmed/33515031
http://dx.doi.org/10.1093/eurheartj/ehaa1097

Ejemplares similares